American Journal of Epidemiology Advance Access published online on October 13, 2006
American Journal of Epidemiology, doi:10.1093/aje/kwj353
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway; Section for Epidemiology and Medical Statistics, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
* To whom correspondence should be addressed. Reports on the association between obesity and lymphohematopoietic malignancies (LHMs) have been inconsistent. The present study aimed at exploring this association for specific disease lymphohematopoietic entities in a large Norwegian cohort. Height and weight were measured in two million Norwegian men and women aged 20-74 years during 1963-2001. During follow-up, 24,500 cases of LHMs were observed. Relative risks of disease were estimated by Cox proportional hazards regression. The risk of LHMs overall increased moderately by increasing body mass index and height in both sexes. The relative risk of LHMs per five-unit increase in body mass index was 1.11 (95% confidence interval (CI): 1.08, 1.14) in men and 1.08 (95% CI: 1.05, 1.11) in women. For each 10-cm increase in height, the relative risk was 1.19 (95% CI: 1.16, 1.22) in men and 1.16 (95% CI: 1.12, 1.20) in women. Separate analyses for different lymphohematopoietic malignancies did not reveal any group's being particularly strongly associated with body mass index. A modest increase in the risk of LHMs combined was observed with increasing height. The moderate associations between height and body mass index and LHMs found in the present study indicate that the observed increase in overweight/obesity plays only a minor role in explaining the increase in the incidence of LHMs.
Received February 15, 2006
Accepted May 26, 2006
ORIGINAL CONTRIBUTIONS
Height and Body Mass Index and Risk of Lymphohematopoietic Malignancies in Two Million Norwegian Men and Women
Anders Engeland 1 *, Steinar Tretli 2, Svein Hansen 2, and Tone Bjørge 1
2 The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Anders Engeland, E-mail: anders.engeland{at}isf.uib.no
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Naganuma, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, A. Hozawa, Y. Nishino, and I. Tsuji Green Tea Consumption and Hematologic Malignancies in Japan: The Ohsaki Study Am. J. Epidemiol., September 15, 2009; 170(6): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Pylypchuk, L. J. Schouten, R. A. Goldbohm, H. C. Schouten, and P. A. van den Brandt Body Mass Index, Height, and Risk of Lymphatic Malignancies: A Prospective Cohort Study Am. J. Epidemiol., August 1, 2009; 170(3): 297 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Strom, Y. Yamamura, H. M. Kantarijian, and J. E. Cortes-Franco Obesity, Weight Gain, and Risk of Chronic Myeloid Leukemia Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lim, T. Gayles, H. A. Katki, R. Stolzenberg-Solomon, S. J. Weinstein, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes Serum High-Density Lipoprotein Cholesterol and Risk of Non-Hodgkin Lymphoma Cancer Res., June 1, 2007; 67(11): 5569 - 5574. [Abstract] [Full Text] [PDF]
|
|